Truist Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.19M | Sell |
9,074
-142
| -2% | -$34.3K | ﹤0.01% | 1226 |
|
2025
Q1 | $2.24M | Buy |
9,216
+30
| +0.3% | +$7.31K | ﹤0.01% | 1164 |
|
2024
Q4 | $3.02M | Buy |
9,186
+72
| +0.8% | +$23.7K | ﹤0.01% | 1046 |
|
2024
Q3 | $3.05M | Buy |
9,114
+183
| +2% | +$61.2K | ﹤0.01% | 1043 |
|
2024
Q2 | $2.44M | Sell |
8,931
-1,742
| -16% | -$476K | ﹤0.01% | 1175 |
|
2024
Q1 | $3.69M | Sell |
10,673
-962
| -8% | -$333K | 0.01% | 999 |
|
2023
Q4 | $3.76M | Sell |
11,635
-3,184
| -21% | -$1.03M | 0.01% | 971 |
|
2023
Q3 | $5.31M | Buy |
14,819
+31
| +0.2% | +$11.1K | 0.01% | 822 |
|
2023
Q2 | $5.61M | Buy |
14,788
+2,046
| +16% | +$776K | 0.01% | 793 |
|
2023
Q1 | $6.1M | Buy |
12,742
+309
| +2% | +$148K | 0.01% | 751 |
|
2022
Q4 | $5.23M | Buy |
12,433
+2,543
| +26% | +$1.07M | 0.01% | 806 |
|
2022
Q3 | $4.13M | Buy |
9,890
+516
| +6% | +$215K | 0.01% | 857 |
|
2022
Q2 | $4.64M | Sell |
9,374
-1,107
| -11% | -$548K | 0.01% | 830 |
|
2022
Q1 | $5.9M | Sell |
10,481
-1,315
| -11% | -$741K | 0.01% | 827 |
|
2021
Q4 | $8.91M | Sell |
11,796
-570
| -5% | -$431K | 0.01% | 680 |
|
2021
Q3 | $9.22M | Buy |
12,366
+298
| +2% | +$222K | 0.02% | 667 |
|
2021
Q2 | $7.78M | Sell |
12,068
-98
| -0.8% | -$63.1K | 0.01% | 720 |
|
2021
Q1 | $6.95M | Buy |
12,166
+992
| +9% | +$567K | 0.01% | 724 |
|
2020
Q4 | $6.51M | Sell |
11,174
-900
| -7% | -$525K | 0.01% | 736 |
|
2020
Q3 | $6.22M | Sell |
12,074
-1,200
| -9% | -$619K | 0.01% | 688 |
|
2020
Q2 | $5.99M | Buy |
13,274
+755
| +6% | +$341K | 0.01% | 672 |
|
2020
Q1 | $4.39M | Buy |
12,519
+106
| +0.9% | +$37.2K | 0.01% | 707 |
|
2019
Q4 | $4.59M | Buy |
12,413
+10,953
| +750% | +$4.05M | 0.01% | 773 |
|
2019
Q3 | $486K | Sell |
1,460
-43
| -3% | -$14.3K | 0.01% | 572 |
|
2019
Q2 | $469K | Buy |
1,503
+47
| +3% | +$14.7K | 0.01% | 595 |
|
2019
Q1 | $445K | Buy |
1,456
+144
| +11% | +$44K | 0.01% | 593 |
|
2018
Q4 | $304K | Buy |
1,312
+177
| +16% | +$41K | 0.01% | 640 |
|
2018
Q3 | $355K | Sell |
1,135
-285
| -20% | -$89.1K | 0.01% | 652 |
|
2018
Q2 | $410K | Buy |
+1,420
| New | +$410K | 0.01% | 618 |
|